← Leaderboards
Arie S Belldegrun
University Of California Los Angeles
$4,603,818
Attributed
$4,603,818
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$4,603,818 · 3
By mechanism
U01$4,187,383 · 1
M01$416,435 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Cromwell E Espineda$95,914
- Sue Ellen Martin$0
- No-Hee Park$1,729,003
- Hal M Morgenstern$1,549,036
- Graeme John Dougherty$1,669,869
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationNeoplasm /Cancer ChemotherapyClinical ResearchHuman Therapy EvaluationHuman SubjectAntineoplasticsNeoplasm /Cancer Remission /RegressionFibroblast Growth FactorGenetic SusceptibilityHigh Throughput TechnologyQuinazolinesAlternative MedicineBiomarkerBladder NeoplasmCancer PreventionChemopreventionCooperative StudyMicroarray TechnologyPatient Oriented ResearchPlant ExtractsPreneoplastic StateProstate NeoplasmsMaleClinical Trial Phase I
Grant awards (11)
Chemoprevention of Superficial Bladder Cancer$1,173,260
U01 · FY2005 · CA
Chemoprevention of Superficial Bladder Cancer$80,000
U01 · FY2005 · CA
Chemoprevention of Superficial Bladder Cancer$1,216,323
U01 · FY2004 · CA
Chemoprevention of Superficial Bladder Cancer$80,000
U01 · FY2004 · CA
Chemoprevention of Superficial Bladder Cancer$391,129
U01 · FY2003 · CA
Chemoprevention of Superficial Bladder Cancer$80,000
U01 · FY2003 · CA
Chemoprevention of Superficial Bladder Cancer$1,166,671
U01 · FY2002 · CA
ADMINISTERING SCH 58500 TO TREAT ADENOCARCINOMA OF PROSTATE$207,266
M01 · FY2001 · RR
ABXEGF IN RENAL/PROSTATE/PANCREATIC/LUNG/ESOPHAGUS CANCE$0
M01 · FY2001 · RR
ADMINISTERING SCH 58500 TO TREAT ADENOCARCINOMA OF PROSTATE$207,266
M01 · FY2000 · RR
ADMINISTERING SCH 58500 TO TREAT ADENOCARCINOMA OF PROSTATE$1,903
M01 · FY2000 · RR